Dr Reddy's Dividend 2024: The board of directors of Dr Reddy's Laboratories has recommended a final dividend of Rs 40 or 800 per cent per equity share for the financial year 2023-24.

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

"Recommended a final dividend of Rs. 40/- (800%) per equity share of Rs. 5/- each for the financial year 2023-24," the company said in an exchange filing on Tuesday.

Dr Reddy's Dividend 2024: Payment Date

The pharma company has not announced the payment date but said that the final dividend will be paid to eligible shareholders on or after five days from the 40th Annual General Meeting. 

"The dividend will be paid on or after five days from the date of declaration of the final dividend by the shareholders at the ensuing 40th Annual General Meeting (AGM) of the Company," the filing reads.

Meanwhile, the pharmaceutical giant has reported a consolidated net profit of Rs 1,307 crore in the fourth quarter of financial year 2024, which is a jump of 36 per cent year-on-year. The company had reported a net profit of Rs 960 crore in the same quarter a year ago. 

The Hyderabad-headquartered drug maker registered revenue of Rs 7,083 crore for the January-March period, up 12.5 per cent on a year-on-year basis, according to a regulatory filing. 

According to Zee Business research, Dr Reddy's Labs' March-quarter net profit was estimated at Rs 1,378 crore and revenue at Rs 7,359 crore.

Revenue from the company's pharmaceutical services and active ingredients unit grew 12.3 per cent to Rs 1,152.6 crore and that from its global generics segment increased 12.8 per cent to Rs 6,119.1 crore, according to the filing.